Following incubation with HCA Healthcare EDs, Augmedix announces the general availability of Augmedix Go in emergency departmentsSAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of Augmedix Go for emergency departments (EDs), marking the launch of the industry’s first fully-automated, generative AI (GenAI) powered medical documentation product for EDs across the cou
On April 11, 2024, Ian Shakil, Chief Strategy Officer of Augmedix Inc (NASDAQ:AUGX), sold 92,787 shares of the company.
On April 8, 2024, Ian Shakil, Chief Strategy Officer of Augmedix Inc (NASDAQ:AUGX), sold 89,167 shares of the company.